Related references
Note: Only part of the references are listed.Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
Rainer H. Boeger et al.
CIRCULATION (2009)
Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
Mathias Gelderblom et al.
STROKE (2009)
Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation
Hayan Dayoub et al.
STROKE (2008)
Asymmetric Dimethyl L-Arginine (ADMA) is a critical regulator of myocardial reperfusion injury
Markus C. Stuehlinger et al.
CARDIOVASCULAR RESEARCH (2007)
A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue
Renke Maas et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men:: Prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data
Renke Maas et al.
CLINICAL CHEMISTRY (2007)
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury
Hakuoh Konishi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
ADMA increases arterial stiffness and decreases cerebral blood flow in humans
Jan T. Kielstein et al.
STROKE (2006)
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
P Wanby et al.
ATHEROSCLEROSIS (2006)
Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
RH Boger
ANNALS OF MEDICINE (2006)
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis
J Jacobi et al.
CIRCULATION (2005)
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence
H Dayoub et al.
CIRCULATION (2003)
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
V Achan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Share Paper
